THINC-IT
LIVE

Serial Number

79213637

Owner

H. Lundbeck A/S

Attorney

Maren C. Perry

Filing Date

Jan 31, 2017

Add to watchlist:

No watchlists yet
View on USPTO

THINC-IT Trademark

Serial Number: 79213637 • Registration: 5516053

THINC-IT is a trademark filed by H. Lundbeck A/S on January 31, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

Trademark Details

Filing Date

January 31, 2017

Registration Date

July 17, 2018

Published for Opposition

May 1, 2018

Goods & Services

[ Pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, diseases, treatment and prevention; scientific and technological services, namely, research in the field of the central nervous system and central nervous system related disorders, diseases and pharmaceuticals; medical research and tests in the field of psychology and neurology; conducting clinical research and tests in the field of psychology and neurology; medical diagnostic research and tests namely, conducting clinical trials for others ]

Downloadable electronic publications in the nature of [ books, reports, ] brochures, [ booklets, ] leaflets, including patient information leaflets, [ magazines, journals, ] teaching and educational material in the field of research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention [ ; computer application software for mobile devices, namely, software for providing information and interaction in the field research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention ]

[ Medical services, therapeutic services and healthcare services, namely, clinical healthcare services; providing medical and healthcare information; services in the field of psychiatry and psychology and medical treatment of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing medical and medicinal information in the field of diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; providing on-line medical data and analyses designed to provide patients and clients customized information, namely, regarding calculation of medical dose, diagnosis, and therapeutic issues and medical management ]

[ Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, cognitive impairment, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; medical diagnostic agents, reagents, preparations and substances for medical purposes; pharmaceutical preparations for treatment of cognitive disorders and diseases ]

[ Medical diagnostic apparatus and instruments for use in diagnosing, managing, monitoring, assessing, controlling and examining symptoms, signs and effects of Alzheimer's disorder and disease, stroke, depression, cognitive impairment, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; injection devices for pharmaceuticals, syringes and needles for injections and medical purposes; integrated medical systems, namely, medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, collecting, storing, monitoring, assessing, controlling and examining patient data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems ]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 13, 2026 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 13, 2025 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Jun 13, 2025 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 13, 2025 APRE
TEAS SECTION 71 RECEIVED
Jan 15, 2025 ES71
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 22, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 22, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 22, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 22, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 22, 2024 COAR
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 17, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 16, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 29, 2018 FICS
FINAL DISPOSITION PROCESSED
Oct 29, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 17, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 17, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 1, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 1, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Apr 27, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 11, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 11, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 11, 2018 OP2R
ELECTRONIC RECORD REVIEW COMPLETE
Mar 26, 2018 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Mar 23, 2018 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 20, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 20, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 20, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 20, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 20, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2018 CRFA
ASSIGNED TO LIE
Feb 22, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2018 TROA
REFUSAL PROCESSED BY IB
Sep 1, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 15, 2017 RFCS
REFUSAL PROCESSED BY MPU
Aug 14, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 11, 2017 RFCR
APPLICATION FILING RECEIPT MAILED
Aug 11, 2017 MAFR
NON-FINAL ACTION WRITTEN
Aug 10, 2017 CNRT
ASSIGNED TO EXAMINER
Aug 7, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 4, 2017 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 3, 2017 REPR